LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Method Detects Bacterial Infection in Preterm Infants

By LabMedica International staff writers
Posted on 12 Apr 2016
Print article
Image: The cobas 8000 modular analyzer system (Photo courtesy of Roche Diagnostics).
Image: The cobas 8000 modular analyzer system (Photo courtesy of Roche Diagnostics).
A new criterion has been proposed for diagnosis of bacterial infection in preterm infants and using this method could lead to early diagnosis and treatment for bacterial infection and improve the prognosis for preterm infants.

Infants born prematurely do not have fully developed immune functions and compared to full-term infants, and if preterm infants suffer a bacterial infection there is a higher chance of fatality or negative impact on future growth and development.

Scientists at Kobe University (Japan) examined 1,267 serums from 283 newborns at the neonatal intensive care unit in Kobe University Hospital between June and December 2014. The enrolled newborns were divided into three infant groups as follows: 37 preterm of less than 34 weeks’ gestational age (GA); 61 late preterm of 34 to 36 weeks’ GA, and 185 term infants equal to or greater than 37 weeks’ GA.

Serum procalcitonin (PCT), was used as a marker used for early detection of bacterial infection in adults and children. Serum PCT measurement was performed using 30 μL of serum, the serum PCT concentration was measured by electrochemical luminescence immunoassay using the COBAS 8000e analyzer (Roche Diagnostics, Basel, Switzerland). The results demonstrated that PCT levels in full-term infants rose temporarily one day after birth, returning to the normal level for adults within five days (0.1ng/mL). However, for preterm infants it took nine days after birth for PCT to return to normal levels. Based on these results, the group plotted two reference curves: 50th percentile and 90th percentile values. When they superimposed three cases of preterm infants with bacterial infection on these curves, it clearly showed that in all three cases the serum PCT concentrations were higher than the 95th percentile values.

The authors concluded that that the physiological feature in preterm infants was significantly different from that in late preterm infants, even in those less than 37 weeks’ gestational age. To detect late-onset bacterial infection and sepsis, an age-specific percentile-based reference curve may be useful in preterm infants. Ichiro Morioka, MD, a professor of pediatrics and senior author of the study said, “We could also potentially use this method to limit unnecessary use of antibacterial agents. Our next step is to verify the precision of diagnoses based on these reference curves.” The study was published on April 1, 2016, in the journal Scientific Reports.

Related Links:

Kobe University 
Roche Diagnostics


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Centromere B Assay
Centromere B Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.